1-10 of 10
William E. Janssen, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Reduction in CMV and Adenovirus Viremia after Haploidentical Donor Transplantation Utilizing CD45RA Depletion and NK Cell Infusion

Brandon M. Triplett, MD, Bradley Muller, Guolian Kang, PhD, Shane J Cross, PharmD, Joseph Moen, Mari H Dallas, MD, Christine Hartford, MD, William E. Janssen, PhD, Ping Law, PhD, Ewelina K. Mamcarz, MD, David R Shook, MD, Ashok Srinivasan, MD, Randall T Hayden, MD, Wing Leung, MD PhD
Journal: Blood
Blood (2015) 126 (23): 624.
https://doi.org/10.1182/blood.V126.23.624.624
Published: 2015
Journal Articles

Tregs Specific for Minor Histocompatibility Antigens

Anandharaman Veerapathran, PhD, Joseph Pidala, MD, MS, Francisca Beato, BS, William E. Janssen, PhD, Xue-Zhong Yu, M.D., M.S., Claudio Anasetti, MD
Journal: Blood
Blood (2012) 120 (21): 1891.
https://doi.org/10.1182/blood.V120.21.1891.1891
Published: 2012
Journal Articles

Purification and Expansion of Antigen-Specific Human Tregs for Clinical Application Using a Single Step CD25 Positive Selection

Francisca Beato, BS, Anandharaman Veerapathran, PhD, Joseph Pidala, MD, MS, William E. Janssen, PhD, Claudio Anasetti, MD
Journal: Blood
Blood (2012) 120 (21): 1899.
https://doi.org/10.1182/blood.V120.21.1899.1899
Published: 2012
Journal Articles

Evaluation of a Risk-Based Algorithm for the Utilization of Plerixafor As Primary Mobilization of CD34+ Cells in Autologous Hematopoietic Cell Transplant Candidates,

Jamie Shapiro, PharmD, Janelle Perkins, PharmD, Ryan Bookout, PharmD, Rebecca Tombleson, PharmD, Ernesto Ayala, MD, William E. Janssen, PhD, Claudio Anasetti, MD, Hugo F. Fernandez, MD
Journal: Blood
Blood (2011) 118 (21): 4060.
https://doi.org/10.1182/blood.V118.21.4060.4060
Published: 2011
Journal Articles

Sirolimus/Tacrolimus Facilitates Preferential Recovery of Regulatory T Cells (Treg) After Allogeneic Hematopoietic Cell Transplantation (HCT), and Is More Effective Than Methotrexate/Tacrolimus in Preventing Grade II-IV Acute Graft Vs. Host Disease (GVHD) and Moderate to Severe Chronic Gvhd

Joseph Pidala, MD, MS, Jongphil Kim, PhD, Heather Jim, PhD, Hugo F. Fernandez, MD, Marcie Tomblyn, MD, MS, Mohamed A Kharfan-Dabaja, MD, Brian C. Betts, MD, Taiga Nishihori, MD, Mian Xu, William E. Janssen, PhD, Frederick L Locke, MD, Ernesto Ayala, MD, Lia Perez, MD, Janelle Perkins, PharmD, Teresa Field, MD, PhD, Leonel Ochoa, Melissa Alsina, MD, Claudio Anasetti, MD
Journal: Blood
Blood (2011) 118 (21): 323.
https://doi.org/10.1182/blood.V118.21.323.323
Published: 2011
Journal Articles

Apheresis of Hematopoietic Progenitor Cell (HPC) From Allogeneic Donors ≥60 Years of Age.

William E. Janssen, PhD, Darlene Rahn, MT, HP, (ASCP), Teresa Field, MD, PhD, Mohamed A Kharfan-Dabaja, MD, Ernesto Ayala, MD, Jose L Ochoa, MD, Martha Hackett, M.P.H., Claudio Anasetti, MD, Hugo F. Fernandez, MD
Journal: Blood
Blood (2009) 114 (22): 4226.
https://doi.org/10.1182/blood.V114.22.4226.4226
Published: 2009
Journal Articles

Sirolimus Yields High Response Rates in Hematopoietic Allograft Recipients with Steroid-Refractory Acute Graft-Versus-Host Disease.

Joseph A. Pidala, MD, Daanish Hoda, Norma Salgado-Vila, Jongphil Kim, PhD, Janelle Perkins, PharmD, Ryan Bookout, PharmD, Teresa Field, MD, PhD, Lia Perez, MD, Ernesto Ayala, MD, J. Leonel Ochoa-Bayona, Jyotishankar Raychaudhuri, Melissa Alsina, MD, John N Greene, MD, William E. Janssen, PhD, Hugo F. Fernandez, MD, Claudio Anasetti, MD, Mohamed A Kharfan-Dabaja, MD
Journal: Blood
Blood (2009) 114 (22): 2235.
https://doi.org/10.1182/blood.V114.22.2235.2235
Published: 2009
Journal Articles

Age Is the Strongest Independent Prognostic Factor in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation: Moffitt Cancer Center Experience

Costanza Paoletti, Lodovico Balducci, MD, Ivette Boler, RN, Mihaela Popa-McKiver, MD, PhD, Martine Externann, MD, PhD, Jyotishankar Raychaudury, MD, Claudio Anasetti, MD, Hugo F. Fernandez, MD, Daniel Sullivan, MD, MS, William S. Dalton, MD, PhD, Teresa Field, Ernesto Ayala, MD, Mohamed A Kharfan-Dabaja, MD, Lia Perez, MD, Janelle Perkins, William E. Janssen, PhD, John Harris, Michael Schell, Rachna Kapoor, MD, MPH, Melissa Alsina, J. Leonel Ochoa-Bayona
Journal: Blood
Blood (2008) 112 (11): 4435.
https://doi.org/10.1182/blood.V112.11.4435.4435
Published: 2008
Journal Articles

Significant Expansion of Myeloid Derived Suppressor Cells in Patients with High- Risk Breast Cancer Treated with Dose Dense Adjuvant Chemotherapy

James E Talmadge, Elizabeth Reed, MD, Kenneth Cowan, Dmitry Gabrilovich, Phyllis Warkentin, William E. Janssen, PhD, James Wisecarver, James Anderson, Mary Mailliard, Sarah Maas, Orhan Turken, Uger Coskun
Journal: Blood
Blood (2008) 112 (11): 4653.
https://doi.org/10.1182/blood.V112.11.4653.4653
Published: 2008
Journal Articles

Phase I Study of Bortezomib, (BTZ) Followed by High-Dose Melphalan, (HD Mel) and BTZ as Conditioning Regimen for Tandem Peripheral Blood Stem Cell Transplants (TanPSCT) in Patients with Primary Refractory Multiple Myeloma (MM) and Plasma Cell Leukemia (PCL).

Todd Alekshun, MD, Christine Mcisaac-Simonelli, RN, Mohamed Kharfan-Dabaja, MD, William Dalton, MD, PhD, Benjamin Djulbegovic, MD, Hugo Fernandez, MD, Daniel M. Sullivan, MD, Ernesto Ayala, MD, Teresa L. Field, MD, Dawn Garrett, LPN, William E. Janssen, PhD, Beth Maddox, RN, Lia Perez, MD, Dawn Kettner, PA, Janelle Perkins, PharmD, Jyoti Raychaudhuri, MD, Claudio Anasetii, MD, Melissa Alsina, MD
Journal: Blood
Blood (2007) 110 (11): 5131.
https://doi.org/10.1182/blood.V110.11.5131.5131
Published: 2007